Farzaneh Bozorg-Ghalati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Farzaneh Bozorg-Ghalati has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Iraj Mohammadpour
Basic Sciences in Infectious Diseases Research center, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications - Ali Akbar Owji
Department of Biochemistry, Shiraz University of Medical Sciences, Shiraz, Iran; Research Center for Psychiatry and Behavioral Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Atefeh Seghatoleslam
Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication Danial Mohammadpour
Department of Dental Surgery, College of Stomatology, Xi’an Jiaotong University Health Science Center, Xi’an, China
1 shared publication- Farhad Ghorbani
Department of Oral and Maxillofacial Surgery, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication Iraj Mohammadpour
Shiraz University of Medical Sciences
1 shared publication
Latest Publications
- Open Access
- 24 November 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1824
Rational utilization of antibiotic prophylaxis in oral and maxillofacial surgery: a large scope review of recent data
Surgical site infections raise the risk of serious health issues following oral and maxillofacial surgeries. There is full consensus that using systemic antibiotics as a prophylactic measure can reduce infection risk in oral and maxillofacial surgical procedures, but the optimal duration and effective usage of these antibiotics remains debated. In light of growing antibiotic resistance, prophylactic use of antibiotics should be evaluated carefully and limited to certain scenarios. Thus, the aim of this scoping review was to summarize the available data regarding the prudent and evidence-based application of prophylactic antibiotics in the realm of oral and maxillofacial surgical interventions. A comprehensive literature search was conducted using published studies from 2000 to 2025 across the Ovid MEDLINE, PubMed, Web of Science, Embase, and Google Scholar databases. We included 25 randomized controlled trials, 60 cohort studies, and 40 systematic reviews. According to the included articles, infection rates ranged from 0% to 62% depending on surgery type. Moreover, various antibiotic types and regimens were used, and in most studies, the follow-up period was short, and the outcomes were not clearly defined. The choice of prophylactic antibiotics depends on the specific surgical procedure and the level of contamination involved. The use of prophylactic antibiotics is advised for surgical extractions of third molars, temporomandibular joint replacements, and clean-contaminated tumor removal surgeries. In compound fractures of the mandible, maxillofacial fractures, and those communicating with paranasal sinuses, prescribing a postoperative course of antibiotics for at least 24 h is necessary, but extended use doesn’t lower infection rates. For dental implants, the evidence supporting prophylaxis in healthy individuals is weak. Prophylactic antibiotics are not routinely advised for fractures of the upper or midfacial thirds. The included studies exhibited substantial differences in design and objectives, making direct comparisons challenging. The findings underscore the importance of short-course, targeted prophylaxis over prolonged empirical regimens to curb resistance. Attention to antimicrobial stewardship and strict adherence to guidelines for antibiotic prophylaxis in oral and maxillofacial surgery are essential to reduce antibiotic misuse and improve the quality of study. More studies are required to provide recommendations for maxillofacial surgical interventions in immunocompromised patients.
- 24 November 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1824
Open AccessRational utilization of antibiotic prophylaxis in oral and maxillofacial surgery: a large scope review of recent data
Surgical site infections raise the risk of serious health issues following oral and maxillofacial surgeries. There is full consensus that using systemic antibiotics as a prophylactic measure can reduce infection risk in oral and maxillofacial surgical procedures, but the optimal duration and effective usage of these antibiotics remains debated. In light of growing antibiotic resistance, prophylactic use of antibiotics should be evaluated carefully and limited to certain scenarios. Thus, the aim of this scoping review was to summarize the available data regarding the prudent and evidence-based application of prophylactic antibiotics in the realm of oral and maxillofacial surgical interventions. A comprehensive literature search was conducted using published studies from 2000 to 2025 across the Ovid MEDLINE, PubMed, Web of Science, Embase, and Google Scholar databases. We included 25 randomized controlled trials, 60 cohort studies, and 40 systematic reviews. According to the included articles, infection rates ranged from 0% to 62% depending on surgery type. Moreover, various antibiotic types and regimens were used, and in most studies, the follow-up period was short, and the outcomes were not clearly defined. The choice of prophylactic antibiotics depends on the specific surgical procedure and the level of contamination involved. The use of prophylactic antibiotics is advised for surgical extractions of third molars, temporomandibular joint replacements, and clean-contaminated tumor removal surgeries. In compound fractures of the mandible, maxillofacial fractures, and those communicating with paranasal sinuses, prescribing a postoperative course of antibiotics for at least 24 h is necessary, but extended use doesn’t lower infection rates. For dental implants, the evidence supporting prophylaxis in healthy individuals is weak. Prophylactic antibiotics are not routinely advised for fractures of the upper or midfacial thirds. The included studies exhibited substantial differences in design and objectives, making direct comparisons challenging. The findings underscore the importance of short-course, targeted prophylaxis over prolonged empirical regimens to curb resistance. Attention to antimicrobial stewardship and strict adherence to guidelines for antibiotic prophylaxis in oral and maxillofacial surgery are essential to reduce antibiotic misuse and improve the quality of study. More studies are required to provide recommendations for maxillofacial surgical interventions in immunocompromised patients.
- Open Access
- 1 January 2024
- Published by Apex Publishing in Iranian Biomedical Journal
- Vol. 28 (1) , 46-52
Melittin as an Activator of the Autophagy and Unfolded Protein Response Pathways in Colorectal HCT116 Cell Line
Background: The surface properties of dental and orthopedic implants are directly related to their osseointegration rate. Coating and/or modifying the implant surface might reduce the time of healing. In this study, we aimed to examine the effects of a hybrid surface consisting of a brushite surface coating and cross-linked water-soluble eggshell membrane protein ...
- 1 January 2024
- Published by Apex Publishing in Iranian Biomedical Journal
- Vol. 28 (1) , 46-52
Open AccessMelittin as an Activator of the Autophagy and Unfolded Protein Response Pathways in Colorectal HCT116 Cell Line
Background: The surface properties of dental and orthopedic implants are directly related to their osseointegration rate. Coating and/or modifying the implant surface might reduce the time of healing. In this study, we aimed to examine the effects of a hybrid surface consisting of a brushite surface coating and cross-linked water-soluble eggshell membrane protein ...
- 22 December 2017
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 28 (1) , 3-10
Applications of fluorescence in situ hybridization in detection of disease biomarkers and personalized medicine
- 22 December 2017
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 28 (1) , 3-10
Applications of fluorescence in situ hybridization in detection of disease biomarkers and personalized medicine
- 11 October 2017
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 17 (3) , 181-188
Molecular Biomarkers of Anaplastic Thyroid Carcinoma
Anaplastic thyroid carcinoma is the rarest but extremely aggressive thyroid cancer subtype. This neoplasia is composed of undifferentiated tumor cells with poor prognosis and resistant to common thyroid cancer therapy. Early stage identification of this cancer for prompt treatment is very vital. Presently, cytological evaluation of fine needle aspiration biopsy (FNAB) which is known as invasive recognition assay, is the standard diagnostic method for the diagnosis of malignant thyroid tumors. Frequent studies have suggested that using the molecular biomarkers of thyroid cancer tissue alongside cytological examination, increase the accuracy of diagnostic tests. Also, these agents could be beneficial for effective target therapy and personalize medicine. In this review, the molecular biomarkers that are involved in anaplastic thyroid carcinoma in four category (gene mutation profile, epigenetic profile, microRNA profile and cancer stem cell markers) were summarized.
- 11 October 2017
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 17 (3) , 181-188
Molecular Biomarkers of Anaplastic Thyroid Carcinoma
Anaplastic thyroid carcinoma is the rarest but extremely aggressive thyroid cancer subtype. This neoplasia is composed of undifferentiated tumor cells with poor prognosis and resistant to common thyroid cancer therapy. Early stage identification of this cancer for prompt treatment is very vital. Presently, cytological evaluation of fine needle aspiration biopsy (FNAB) which is known as invasive recognition assay, is the standard diagnostic method for the diagnosis of malignant thyroid tumors. Frequent studies have suggested that using the molecular biomarkers of thyroid cancer tissue alongside cytological examination, increase the accuracy of diagnostic tests. Also, these agents could be beneficial for effective target therapy and personalize medicine. In this review, the molecular biomarkers that are involved in anaplastic thyroid carcinoma in four category (gene mutation profile, epigenetic profile, microRNA profile and cancer stem cell markers) were summarized.
- 16 June 2017
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 26 (4) , 981-983
Are surface markers of cancer stem cells reliable factors for cancer treatment follow-up?
- 16 June 2017
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 26 (4) , 981-983
Are surface markers of cancer stem cells reliable factors for cancer treatment follow-up?
- 1 September 2011
- Published by Elsevier in Clinical Biochemistry
- Vol. 44 (13) , S73-S74
The new human gene, UBE2Q1, with putative ubiquitin conjugating enzyme activity is down-regulated in Acute Lymphoblastic Leukemia (ALL)
- 1 September 2011
- Published by Elsevier in Clinical Biochemistry
- Vol. 44 (13) , S73-S74
The new human gene, UBE2Q1, with putative ubiquitin conjugating enzyme activity is down-regulated in Acute Lymphoblastic Leukemia (ALL)